All Stories

  1. Discovery and Structure–Activity Relationships of Novel ssDAF-12 Receptor Modulators
  2. Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency
  3. Multiple Heart-Cutting Two-Dimensional HPLC-UV Achiral–Chiral Analysis of Branched-Chain Amino Acids in Food Supplements under Environmentally Friendly Conditions
  4. Synthesis and Characterization of Chiral Iridium Complexes Bearing Carbohydrate Functionalized Pyridincarboxamide Ligands and Their Application as Catalysts in the Asymmetric Transfer Hydrogenation of α-Ketoacids in Water
  5. Environmentally Sustainable Achiral and Chiral Chromatographic Analysis of Amino Acids in Food Supplements
  6. Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties
  7. Combining molecular modeling approaches to establish the chromatographic enantiomer elution order in the absence of pure enantiomeric standards: A study case with two tetracyclic quinolines
  8. Elucidation of retention mechanism of dipeptides on a Ristocetin A-based chiral stationary phase using a combination of chromatographic and molecular simulation techniques
  9. Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls
  10. Enantioseparation of novel anti-inflammatory chiral sulfoxides with two cellulose dichlorophenylcarbamate-based chiral stationary phases and polar-organic mobile phase(s)
  11. Efficient enantioresolution of aromatic α-hydroxy acids with Cinchona alkaloid-based zwitterionic stationary phases and volatile polar-ionic eluents
  12. Original enantioseparation of illicit fentanyls with cellulose-based chiral stationary phases under polar-ionic conditions
  13. Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis
  14. Synthesis and biological activity of cyclopropyl Δ7-dafachronic acids as DAF-12 receptor ligands
  15. Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome
  16. Integrating experimental and computational techniques to study chromatographic enantioresolutions of chiral tetrahydroindazole derivatives
  17. Fragment-based Design of Zwitterionic, Strong Cation- and Weak Anion-Exchange Type Mixed-mode Liquid Chromatography Ligands and their Chromatographic Exploration
  18. New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures.
  19. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers
  20. Binding modes identification through molecular dynamic simulations: a case study with carnosine enantiomers and the Teicoplanin A2‐2‐based chiral stationary phase
  21. Discovery of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by Exploiting a Multistep Virtual Screening Protocol
  22. Enantioselective HPLC Analysis to Assist the Chemical Exploration of Chiral Imidazolines
  23. Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations
  24. Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l ‐Trp to Indoleamine 2,3‐Dioxygenase 1
  25. Mixed-mode Chromatography Characteristics of Chiralpak ZWIX(+) and ZWIX(–) and Elucidation of their Chromatographic Orthogonality for LC×LC Application
  26. Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists
  27. Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool
  28. Hydrophilic interaction liquid chromatography of aminoglycoside antibiotics with a diol-type stationary phase
  29. α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis
  30. Elucidation of the Chromatographic Enantiomer Elution Order Through Computational Studies
  31. Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification
  32. Exploring the enantiorecognition mechanism of Cinchona alkaloid-based zwitterionic chiral stationary phases and the basic trans -paroxetine enantiomers
  33. Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors
  34. Binding properties of different categories of IDO1 inhibitors: a microscale thermophoresis study
  35. Reshaping antibiotics through hydrophobic drug-bile acid ionic complexation enhances activity against Staphylococcus aureus biofilms
  36. Enantioresolution and stereochemical characterization of two chiral sulfoxides endowed with COX-2 inhibitory activity
  37. A rational approach to elucidate human monoamine oxidase molecular selectivity
  38. N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for “green” ligand-exchange chromatography applications
  39. Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders
  40. Synthesis and biological evaluation of C(5)-substituted derivatives of leukotriene biosynthesis inhibitor BRP-7
  41. The “racemic approach” in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives
  42. Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure
  43. 4,5-Diarylisoxazol-3-carboxylic acids: A new class of leukotriene biosynthesis inhibitors potentially targeting 5-lipoxygenase-activating protein (FLAP)
  44. Mechanistic considerations of enantiorecognition on novel Cinchona alkaloid-based zwitterionic chiral stationary phases from the aspect of the separation of trans-paroxetine enantiomers as model compounds
  45. The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities
  46. Quinine-Based Zwitterionic Chiral Stationary Phase as a Complementary Tool for Peptide Analysis: Mobile Phase Effects on Enantio- and Stereoselectivity of Underivatized Oligopeptides
  47. Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors
  48. Diastereo- and enantioseparation of a Nα-Boc amino acid with a zwitterionic quinine-based stationary phase: Focus on the stereorecognition mechanism
  49. N-Aryl-5-aminopyrazole: A Versatile Architecture in Medicinal Chemistry
  50. Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
  51. Scaffold hopping approach on the route to selective tankyrase inhibitors
  52. Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy
  53. Enantioresolution, stereochemical characterization and biological activity of a chiral large-conductance calcium-activated potassium channel opener
  54. Ketoprofen enantioseparation with a Cinchona alkaloid based stationary phase: Enantiorecognition mechanism and release studies
  55. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors
  56. Chromatographic separation of free dafachronic acid epimers with a novel triazole click quinidine-based chiral stationary phase
  57. Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3- b ]pyridazin-8-amine Derivatives as Tankyrase Inhibitors
  58. One-pot, telescoped synthesis of N-aryl-5-aminopyrazoles from anilines in environmentally benign conditions
  59. From Polypharmacology to Target Specificity: The Case of PARP Inhibitors
  60. Synthesis and Biological Evaluation of Direct Thrombin Inhibitors Bearing 4-(Piperidin-1-yl)pyridine at the P1 Position with Potent Anticoagulant Activity
  61. Exploring the effect of PARP-1 flexibility in docking studies
  62. Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: Role of the chirality on the biological activity
  63. Navigations of chemical space to further the understanding of polypharmacology in human nuclear receptors
  64. Chiral mobile phase in ligand-exchange chromatography of amino acids: Exploring the copper(II) salt anion effect with a computational approach
  65. Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists
  66. Extending SAR of bile acids as FXR ligands: Discovery of 23-N-(carbocinnamyloxy)-3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-amine
  67. Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
  68. Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ
  69. Molecular Interaction Fields and 3D-QSAR Studies of p53−MDM2 Inhibitors Suggest Additional Features of Ligand−Target Interaction
  70. Quantum mechanics/molecular mechanics (QM/MM) modeling of the irreversible transamination of l-kynurenine to kynurenic acid: The round dance of kynurenine aminotransferase II
  71. Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition
  72. Fluorinated Benzyloxyphenyl Piperidine-4-carboxamides with Dual Function against Thrombosis: Inhibitors of Factor Xa and Platelet Aggregation
  73. Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition
  74. Sequence Variants in Kynurenine Aminotransferase II (KAT II) Orthologs Determine Different Potencies of the InhibitorS-ESBA
  75. An Integrated Approach to Ligand- and Structure-Based Drug Design: Development and Application to a Series of Serine Protease Inhibitors
  76. Synthesis and Monoamine Oxidase Inhibitory Activity of New Pyridazine-, Pyrimidine- and 1,2,4-Triazine-Containing Tricyclic Derivatives
  77. Ester derivatives of annulated tetrahydroazocines: A new class of selective acetylcholinesterase inhibitors
  78. Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches
  79. The natural mutation by deletion of Lys9 in the thrombin A-chain affects the pKa value of catalytic residues, the overall enzyme's stability and conformational transitions linked to Na+ binding
  80. Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides
  81. A Natural Prothrombin Mutant Reveals an Unexpected Influence of A-chain Structure on the Activity of Human  -Thrombin
  82. High affinity central benzodiazepine receptor ligands. Part 3: insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo[4,3- c ]quinolin-3-ones
  83. Investigation on the antiplatelet activity of pyrrolo[3,2-c]pyridine-containing compounds
  84. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. synthesis and SAR studies